Drug profile · INN
bromodiphenhydramine hydrochloride
AMBENYL
bromodiphenhydramine hydrochloride (AMBENYL) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — bromodiphenhydramine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
bromodiphenhydramine hydrochloride (AMBENYL) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is bromodiphenhydramine hydrochloride?
bromodiphenhydramine hydrochloride (AMBENYL) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for bromodiphenhydramine hydrochloride?
AMBENYL is a marketed brand name for bromodiphenhydramine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bromodiphenhydramine hydrochloride?
bromodiphenhydramine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.